Great Lakes Dental Technologies announced an exclusive lab partnership with TAP Sleep Care (Airway Management) to launch the groundbreaking Nylon flexTAP®, the world’s first FDA-cleared, single-point midline digitally printed nylon oral appliance for the treatment of snoring and mild to moderate obstructive sleep apnea (OSA). This strategic collaboration brings together […]
Industry News
Acquisitions | Awards | Events | News | Partnerships
Narcolepsy Network Appoints Liz Burgess as New Executive Director
Narcolepsy Network, a national non-profit organization for people living with narcolepsy and idiopathic hypersomnia (IH), is pleased to announce the appointment of Liz Burgess as its new Executive Director. Liz has dedicated her career to mission-driven leadership, serving for more than 20 years as an Executive Director of a diverse range of nonprofit […]
Sleep Medicine Physician Dr. Funke Afolabi-Brown Launches Online Insomnia Program, Joins HumanUp as Expert Sleep Partner
Dr. Funke Afolabi-Brown, a board-certified sleep medicine physician and founder of The Restful Sleep Place, is expanding her national reach through a series of initiatives, including a new role as sleep expert for the parenting platform HumanUp, a feature in Sleep Review Magazine, and the launch of a comprehensive online insomnia program […]
sovaSage Named a Top 10 Sleep Therapy Solution Provider for 2026
sovaSage has been named one of the Top 10 Sleep Therapy Solution Providers for 2026 by Healthcare Business Outlook. This recognition underscores sovaSage’s role in transforming how sleep therapy is delivered, combining advanced analytics, behavioral science, and human-centered design to improve patient outcomes and operational efficiency across the care continuum. […]
Narcolepsy Network Announces Addition of Two New Board Members
Narcolepsy Network, a national non-profit organization for people living with narcolepsy and idiopathic hypersomnia (IH), is proud to announce the appointment of Desireé Gorbea-Finalet and Mike Heil to its Board of Directors. Both new members live with narcolepsy and will bring fresh perspectives and deep advocacy experience to the organization as it prepares to […]
NightWare Announce Strategic Investment Partnership
NightWare, Inc. and Exit 156 Capital announced a strategic investment by Exit 156 in NightWare’s ongoing Series C financing. NightWare is the maker of the only FDA-cleared prescription digital therapeutic indicated for nightmare disorder in adults with post-traumatic stress disorder (PTSD). The partnership unites a Minneapolis-based growth-stage digital health company […]
Dreem Health Joins Amazon’s Health Benefits Connector As The Platform’s First Sleep Health Provider
Dreem Health, a leading virtual sleep clinic managed by Sunrise Group, has become the first sleep care service to join Amazon’s Health Benefits Connector. Amazon customers eligible for insurance-covered sleep services can discover and enroll in Dreem Health’s personalized care when browsing for healthcare services. More than 70 million Americans live with sleep […]
ProSomnus Receives FDA Class II Clearance for RPMO₂ OSA Device
ProSomnus Sleep Technologies announced that the U.S. Food and Drug Administration (FDA) has granted Class II 510(k) clearance for its RPMO₂ OSA Device under the product codes DQA, LQZ, LRK, PLC, and OUG (FDA K252765). The RPMO2 OSA Device is the first theragnostic device for sleep medicine, incorporating both precision […]
Apnimed Secures $150M to Advance AD109 Toward Launch
Apnimed, Inc., announced that it has entered into a senior secured credit facility for up to $150 million with funds managed by HealthCare Royalty Partners (“HCRx”). The capital is expected to support commercial readiness activities and the planned U.S. launch of Apnimed’s lead product candidate, AD109, if approved by the […]
Sleep Physician Sentenced for CPAP Fraud Case
On March 25, United States District Court Judge Rebecca L. Pennell sentenced Dr. Eric Edward Haeger, age 57, of Brewster, Washington, to one year and a day in federal prison followed by a one-year term of supervised release after Haeger pleaded guilty to adulterating and misbranding medical devices with the […]













